Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen into s.c. lymph nodes. The objective was to evaluate safety and efficacy compared with conventional s.c. immunotherapy. In a monocentric open-label trial, 165 patients with grass pollen-induced rhinoconjunctivitis were randomized to receive either 54 s.c. injections with pollen extract over 3 years [cumulative allergen dose 4,031,540 standardized quality units (SQ-U)] or 3 intralymphatic injections over 2 months (cumulative allergen dose 3,000 SQ-U). Patients were evaluated after 4 months, 1 year, and 3 years by nasal provocation, skin prick testing, IgE measurements, and symptom scores. Three low-dose intralymphatic allergen administrations increased tolerance to nasal provocation with pollen already within 4 months ( P < 0.001). Tolerance was long lasting and equivalent to that achievable after standard s.c. immunotherapy ( P = 0.291 after 3 years). Intralymphatic immunotherapy ameliorated hay fever symptoms ( P < 0.001), reduced skin prick test reactivity ( P < 0.001), decreased specific serum IgE ( P < 0.001), caused fewer adverse events than s.c. immunotherapy ( P = 0.001), enhanced compliance ( P < 0.001), and was less painful than venous puncture ( P = 0.018). In conclusion, intralymphatic allergen administration enhanced safety and efficacy of immunotherapy and reduced treatment time from 3 years to 8 weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The major advantages of this route of allergen application are the markedly reduced duration of immunotherapy treatment (both time spent and number of visits) and the much lower amount of allergen required to achieve results.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Clinical trials have illustrated that a reduction in AR symptoms can be achieved with just 3 doses of injected allergen, with a dosage interval of 1 month1716-1720 (Table IX.D.6).”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“In 2008, Senti et al.1716 compared ILIT to SCIT and not to placebo.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Most trials1716,1718-1721 used commercially available grass pollen or birch pollen allergen extract as the antigen.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Of the 6 trials published thus far, 5 have demonstrated clinical efficacy and safety.1716-1720”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
Citations
Cites
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., & Nouri-Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,373
Möller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Position Paper: Allergen standardization and skin tests
Dreborg, S., & Frew, A. (1993) · Allergy · doi:10.1111/j.1398-9995.1993.tb04756.x · Cited by 753
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R., Malling, H. J., Alvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. J., Dayer, J. M., Durham, S. R., Demoly, P., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 736
Arbes Jr., S. J., Gergen, P. J., Elliott, L., & Zeldin, D. C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.017 · Cited by 639 · cited 1×
“I allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, affecting up to 35% of the population in westernized countries (1).”
BackgroundPajno, G. B., Barberio, G., De Luca, F., Morabito, L., & Parmiani, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01161.x · Cited by 546
Varney, V. A., Gaga, M., Frew, A. J., Aber, V. R., Kay, A. B., & Durham, S. R. (1991) · BMJ · doi:10.1136/bmj.302.6771.265 · Cited by 384
Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs
Kündig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. J. L., Battegay, M., Lother, H., Gessner, A., Kühlcke, K., Ohashi, P. S., Hengartner, H., et al. (1995) · Science · doi:10.1126/science.7761853 · Cited by 301
Self-citation(1993) · PubMed · Cited by 221
Research works printed but not linked: 1
- Epidemiology Surveys and Danske Equities (ALK-Abelló, Hørsholm, Denmark, 2005).
Cited by
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
Shamji, M. H., & Durham, S. R. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.010 · Cited by 446
Burks, A. W., Calderon, M. A., Casale, T., Cox, L., Demoly, P., Jutel, M., Nelson, H., & Akdis, C. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.049 · Cited by 438
Allergen immunotherapy: past, present and future
Durham, S. R., & Shamji, M. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00786-1 · Cited by 413
Shamji, M. H., Kappen, J. H., Akdis, M., Jensen‐Jarolim, E., Knol, E. F., Kleine‐Tebbe, J., Bohle, B., Chaker, A. M., Till, S. J., Valenta, R., et al. (2017) · Allergy · doi:10.1111/all.13138 · Cited by 382
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
Pfaar, O., Bachert, C., Bufe, A., Buhl, R., Ebner, C., Eng, P., Friedrichs, F., Fuchs, T., Hamelmann, E., Hartwig-Bade, D., et al. (2014) · Allergo Journal International · doi:10.1007/s40629-014-0032-2 · Cited by 351
Therapies for allergic inflammation: refining strategies to induce tolerance
Akdis, C. A. (2012) · Nature Medicine · doi:10.1038/nm.2754 · Cited by 296
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271
Self-citationJewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Mechanism of action of mRNA-based vaccines
Iavarone, C., O’hagan, D. T., Yu, D., Delahaye, N. F., & Ulmer, J. B. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1355245 · Cited by 234
Mohanan, D., Slütter, B., Henriksen-Lacey, M., Jiskoot, W., Bouwstra, J. A., Perrie, Y., Kündig, T. M., Gander, B., & Johansen, P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.012 · Cited by 229
Self-citationTherapeutic manipulation of immune tolerance in allergic disease
Akdis, M., & Akdis, C. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2653 · Cited by 195
DeMuth, P. C., Garcia‐Beltran, W. F., Ai‐Ling, M. L., Hammond, P. T., & Irvine, D. J. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201201512 · Cited by 166
Palomares, O., Rückert, B., Jartti, T., Kücüksezer, U. C., Puhakka, T., Gomez, E., Fahrner, H. B., Speiser, A., Jung, A., Kwok, W. W., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.031 · Cited by 167
Immunotherapy for allergic rhinitis
Walker, S. M., Durham, S. R., Till, S. J., Roberts, G., Corrigan, C. J., Leech, S. C., Krishna, M. T., Rajakulasingham, R. K., Williams, A., Chantrell, J., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03794.x · Cited by 156
Hylander, T., Latif, L., Petersson-Westin, U., & Cardell, L. O. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.056 · Cited by 141
Allergic rhinitis: An update on disease, present treatments and future prospects
Mandhane, S. N., Shah, J. H., & Thennati, R. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.07.005 · Cited by 144
Past, present, and future of allergen immunotherapy vaccines
Dorofeeva, Y., Shilovskiy, I. P., Tulaeva, I., Focke‐Tejkl, M., Flicker, S., Kudlay, D. A., Khaitov, M. R., Васильевна, К. А., Riabova, K. A., Karaulov, A. V., et al. (2020) · Allergy · doi:10.1111/all.14300 · Cited by 139
Allergen Immunotherapy: Current and Future Trends
Pavón-Romero, G. F., Parra-Vargas, M. I., Jiménez, F. R., Melgoza-Ruiz, E., Serrano-Pérez, N. H., & Teran, L. M. (2022) · Cells · doi:10.3390/cells11020212 · Cited by 139
Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy
Martínez-Gómez, J. M., Johansen, P., Erdmann, I., Senti, G., Crameri, R., & Kündig, T. M. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000210381 · Cited by 118
Self-citationExploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
Maisel, K., Sasso, M. S., Potin, L., & Swartz, M. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.005 · Cited by 113
Engineering Strategies for Lymph Node Targeted Immune Activation
Chen, Y., Koker, S. D., & Geest, B. G. D. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00260 · Cited by 119
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT)
Ring, J., & Gutermuth, J. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02541.x · Cited by 112
Allergen‐specific immunotherapy: from therapeutic vaccines to prophylactic approaches
Valenta, R., Campana, R., Marth, K., & van Hage, M. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02556.x · Cited by 112
In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance
Pearson, R. M., Casey, L. M., Hughes, K. R., Miller, S. D., & Shea, L. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.005 · Cited by 120
The mouse lymph node as an ectopic transplantation site for multiple tissues
Komori, J., Boone, L., DeWard, A., Hoppo, T., & Lagasse, E. (2012) · Nature Biotechnology · doi:10.1038/nbt.2379 · Cited by 109
Choi, E. S., Song, J., Kang, Y. Y., & Mok, H. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900042 · Cited by 109
Hadamitzky, C., Spohr, H., Debertin, A. S., Guddat, S. S., Tsokos, M., & Pabst, R. (2010) · Journal of Anatomy · doi:10.1111/j.1469-7580.2010.01213.x · Cited by 108
Intralymphatic Immunotherapy: Update and Unmet Needs
Senti, G., Freiburghaus, A. U., Larenas-Linnemann, D., Hoffmann, H. J., Patterson, A. M., Klimek, L., Di Bona, D., Pfaar, O., Ahlbeck, L., Akdis, M., et al. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000493647 · Cited by 103
Self-citationImmunotherapy: What lies beyond
Casale, T. B., & Stokes, J. R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.007 · Cited by 109
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten, M., Malling, H.-J., Blom, L., Poulsen, B. C., & Poulsen, L. K. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.033 · Cited by 100
Allergen Immunotherapy: Past, Present, and Future
Jutel, M., Kosowska, A., & Smolińska, S. (2016) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2016.8.3.191 · Cited by 99
The ReNAissanCe of mRNA-based cancer therapy
Van Lint, S., Renmans, D., Broos, K., Dewitte, H., Lentacker, I., Heirman, C., Breckpot, K., & Thielemans, K. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.957685 · Cited by 95
“Moreover, it is now clear that lymph nodes are poorly enervated, which limits the severity of pain to the penetration of the skin [86].”
BackgroundMethodNovel approaches and perspectives in allergen immunotherapy
Hoffmann, H. J., Valovirta, E., Pfaar, O., Moingeon, P., Schmid, J. M., Skaarup, S. H., Cardell, L. ‐., Simonsen, K., Larché, M., Durham, S. R., et al. (2017) · Allergy · doi:10.1111/all.13135 · Cited by 96
Hylander, T., Larsson, O., Petersson-Westin, U., Eriksson, M., Kumlien Georén, S., Winqvist, O., & Cardell, L.-O. (2016) · Respiratory Research · doi:10.1186/s12931-016-0324-9 · Cited by 92
Casale, T. B., & Stokes, J. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.034 · Cited by 98
Super natural killer cells that target metastases in the tumor draining lymph nodes
Chandrasekaran, S., Chan, M. F., Li, J., & King, M. R. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.001 · Cited by 87
Clinical reviews in allergy and immunology
Leung, D. Y. M., Ledford, D. K., Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., et al. (2012) · Cited by 87
Senti, G., Johansen, P., & Kündig, T. M. (2009) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3283310ff7 · Cited by 86
Self-citationHarnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
Andorko, J. I., Hess, K. L., & Jewell, C. M. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9708-2 · Cited by 83
Rohner, N. A., & Thomas, S. N. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00438 · Cited by 82
Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update
Wang, C., Bao, Y., Chen, J., Chen, X., Cheng, L., Guo, Y. S., Hao, C., Lai, H., Li, H., Li, J., et al. (2022) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2022.14.6.604 · Cited by 90
Allergen immunotherapy for long-term tolerance and prevention
Penagos, M., & Durham, S. R. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.007 · Cited by 83
Patterson, A. M., Bonny, A. E., Shiels, W. E., & Erwin, E. A. (2016) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.11.010 · Cited by 74
New approaches to allergen immunotherapy
Gunawardana, N. C., & Durham, S. R. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.07.014 · Cited by 75
Mechanisms of Allergen-Specific Immunotherapy and Novel Ways for Vaccine Development
Jutel, M., van de Veen, W., Agache, I. O., Azkur, K. A., Akdis, M., & Akdiş, C. A. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0608 · Cited by 73
Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
Curin, M., Khaitov, M. R., Karaulov, A. V., Namazova-Baranova, L. S., Campana, R., Garib, V., & Valenta, R. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0790-x · Cited by 73
Lympho-geographical concepts in vaccine delivery
Johansen, P., Mohanan, D., Martínez-Gómez, J. M., Kündig, T. M., & Gander, B. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.019 · Cited by 74
Self-citationUpdate in the Mechanisms of Allergen-Specific Immunotheraphy
Akkoç, T., Akdiş, M., & Akdiş, C. A. (2010) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2011.3.1.11 · Cited by 80
Senti, G., von Moos, S., & Kündig, T. M. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02560.x · Cited by 65
Self-citationAluminium in allergen-specific subcutaneous immunotherapy – A German perspective
Kramer, M. F., & Heath, M. D. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.063 · Cited by 64
Induction of Tolerance via the Sublingual Route: Mechanisms and Applications
Moingeon, P. E., & Mascarell, L. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/623474 · Cited by 71
New Directions in Immunotherapy
Cox, L., Compalati, E., Kündig, T. M., & Larché, M. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0335-7 · Cited by 66
Self-citationPassalacqua, G., & Canonica, G. W. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.001 · Cited by 67
Calderón, M. A., Cardona, V., Demoly, P. M., & Panel, O. B. O. T. E. 1. Y. O. I. E. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02785.x · Cited by 71
Engineering self-assembled materials to study and direct immune function
Tostanoski, L. H., & Jewell, C. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.005 · Cited by 62
Hellkvist, L., Hjalmarsson, E., Georén, S. K., Karlsson, A., Lundkvist, K., Winqvist, O., Westin, U., & Cardell, L. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.030 · Cited by 60
Ludvigsson, J., Sumnik, Z., Pelikanova, T., Nattero Chavez, L., Lundberg, E., Rica, I., Martínez-Brocca, M. A., Ruiz de Adana, M., Wahlberg, J., Katsarou, A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0318 · Cited by 58
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
Klimek, L., Kündig, T. M., Kramer, M. F., Guethoff, S., Jensen‐Jarolim, E., Schmidt‐Weber, C. B., Palomares, O., Mohsen, M. O., Jakob, T., & Bachmann, M. F. (2018) · Allergo Journal International · doi:10.1007/s40629-018-0074-y · Cited by 59
Self-citationOne hundred years of allergen immunotherapy: Time to ring the changes
Durham, S. R., & Leung, D. Y. M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.032 · Cited by 59
Chinese Guideline on allergen immunotherapy for allergic rhinitis
Bao, Y., Chen, J., Cheng, L., Guo, Y., Hong, S., Kong, W., Lai, H., Li, H., Li, H., Li, J., et al. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.10.112 · Cited by 62
Intralymphatic immunotherapy: Time interval between injections is essential
Kündig, T. M., Johansen, P., Bachmann, M. F., Cardell, L., & Senti, G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.036 · Cited by 56
Self-citationA Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies
Lee, S. P., Choi, S. J., Joe, E., Lee, S. M., Lee, M. W., Shim, J. W., Kim, Y. J., Kyung, S. Y., Park, J.-W., Jeong, S. H., et al. (2017) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2017.9.3.272 · Cited by 56
The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy
Bächer, P., & Scheffold, A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.016 · Cited by 56
Sharif, H., Singh, I., Kouser, L., Mösges, R., Bonny, M.-A., Karamani, A., Parkin, R. V., Bovy, N., Kishore, U., Robb, A. O., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.02.023 · Cited by 58
Allergen-Specific Immunotherapy: Which Outcome Measures are Useful in Monitoring Clinical Trials?
Pfaar, O., Kleine‐Tebbe, J., Hörmann, K., & Klimek, L. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.004 · Cited by 58
Clinical immunology review series: an approach to desensitization
Krishna, M. T., & Huissoon, A. P. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04296.x · Cited by 59
Allergen-specific immunotherapy: is it vaccination against toxins after all?
Bachmann, M. F., & Kündig, T. M. (2017) · Allergy · doi:10.1111/all.12890 · Cited by 52
Self-citationSkaarup, S. H., Schmid, J. M., Skjold, T., Graumann, O., & Hoffmann, H. J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.002 · Cited by 53
Cox, L., Calderón, M. A., & Pfaar, O. (2012) · Immunotherapy · doi:10.2217/imt.12.36 · Cited by 54
Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine
Zaleska, A., Eiwegger, T., Soyer, Ö., van de Veen, W., Rhyner, C., Soyka, M. B., Bekpen, C., Demiröz, D., Treis, A., Söllner, S., et al. (2014) · Allergy · doi:10.1111/all.12461 · Cited by 50
Self-citationHesse, L., Elberink, J. N. G. O., van Oosterhout, A. J. M., & Nawijn, M. C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108115 · Cited by 53
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy
Exley, C. (2014) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-10-4 · Cited by 55
Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases
Smarr, C. B., Bryce, P. J., & Miller, S. D. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007046 · Cited by 56
Konradsen, J. R., Grundström, J., Hellkvist, L., Tran, T. A. T., Andersson, N., Gafvelin, G., Kiewiet, M. B. G., Hamsten, C., Tang, J., Parkin, R. V., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.017 · Cited by 47
Senti, G., & Kündig, T. M. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-014-0047-7 · Cited by 49
Self-citationEpicutaneous Immunotherapy for Aeroallergen and Food Allergy
Senti, G., Moos, S. C. V., & Kündig, T. M. (2013) · Current Treatment Options in Allergy · doi:10.1007/s40521-013-0003-8 · Cited by 49
Self-citationIntra-lymph Node Injection of Biodegradable Polymer Particles
Andorko, J. I., Tostanoski, L. H., Solano, E., Mukhamedova, M., & Jewell, C. M. (2014) · Journal of Visualized Experiments · doi:10.3791/50984 · Cited by 48
Malaria's deadly secret: a skin stage
Guilbride, D. L., Guilbride, P. D. L., & Gawliński, P. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.01.002 · Cited by 56
Impact of nanoparticle properties on immune cell interactions in the lymph node
Farooq, M. A., Johnston, A. P. R., & Trevaskis, N. L. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.039 · Cited by 52
Allergen immunotherapy for allergic respiratory diseases
Cappella, A., & Durham, S. R. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21629 · Cited by 55
Allergen immunotherapy in allergic rhinitis: current use and future trends
Klimek, L., Pfaar, O., Bousquet, J. J., Senti, G., & Kündig, T. M. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1333423 · Cited by 43
Self-citationTackling Autoimmunity with Nanomedicines
Feng, X., Liu, J., Xu, W., Gao, L., & Ding, J. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0102 · Cited by 43
Sestak, J. O., Sullivan, B. P., Thati, S., Northrup, L., Hartwell, B. L., Antúnez, L. R., Forrest, M. L., Vines, C. M., Siahaan, T. J., & Berkland, C. J. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.8 · Cited by 49
Is The Allergen Really Needed in Allergy Immunotherapy?
Kündig, T. M., Klimek, L., Schendzielorz, P., Renner, W. A., Senti, G., & Bachmann, M. F. (2014) · Current Treatment Options in Allergy · doi:10.1007/s40521-014-0038-5 · Cited by 45
Self-citationNovel Delivery Routes for Allergy Immunotherapy
Senti, G., & Kündig, T. M. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.006 · Cited by 41
Self-citationAllergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
Boonpiyathad, T., Lao‐Araya, M., Chiewchalermsri, C., Sangkanjanavanich, S., & Morita, H. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.747323 · Cited by 46
Hymenoptera Venom Immunotherapy
Bilò, M. B., & Bonifazi, F. (2011) · Immunotherapy · doi:10.2217/imt.10.88 · Cited by 44
Schmid, J. M., Nezam, H., Madsen, H. H. T., Schmitz, A., & Hoffmann, H. J. (2016) · Clinical and Translational Allergy · doi:10.1186/s13601-016-0107-x · Cited by 41
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future
Pfaar, O., Creticos, P. S., Kleine‐Tebbe, J., Canonica, G. W., Palomares, Ó., & Schülke, S. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.12.067 · Cited by 70
Future of allergic rhinitis management
Linton, S., Burrows, A. G., Hossenbaccus, L., & Ellis, A. K. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.04.029 · Cited by 44
Rotiroti, G., Shamji, M. H., Durham, S. R., & Till, S. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.052 · Cited by 39
Gammon, J. M., Carey, S. T., Saxena, V., Eppler, H. B., Tsai, S. J., Paluskievicz, C., Xiong, Y., Li, L., Ackun‐Farmmer, M. A., Tostanoski, L. H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36225-5 · Cited by 39
Intralymphatic Immunotherapy: From the Rationale to Human Applications
Senti, G., Johansen, P., & Kündig, T. M. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_133 · Cited by 41
Self-citationGuilbride, D. L., Gawliński, P., & Guilbride, P. D. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010685 · Cited by 49
New routes for allergen immunotherapy
Johansen, P., Moos, S. C. V., Mohanan, D., Kündig, T. M., & Senti, G. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21948 · Cited by 39
Self-citation
Metadata
- Authors
- Senti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., Johansen, P., & Kündig, T. M.
- Affiliations
- University Hospital Zurich (CH)
- Unit for Experimental Immunotherapy, Department of Dermatology, and
- MannKind Corporation (United States) (US)
- Swiss Institute for Asthma and Allergy Research, 7270 Davos, Switzerland
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-11-18
- Volume
- 105
- Issue
- 46
- Pages
- 17908-17912
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2582048
- OpenAlex
- W1975755712
- Cited by
- 364
- References
- 26
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 14 · 2023: 22 · 2022: 26 · 2021: 18 · 2020: 21 · 2019: 12 · 2018: 18 · 2017: 23 · 2016: 24 · 2015: 19 · 2014: 35 · 2013: 30 · 2012: 26
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114634, 310000)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, subcutaneous immunotherapy, grass pollen allergy, rhinoconjunctivitis, allergic rhinitis, IgE-mediated allergy, lymph node injection, treatment duration, treatment safety, medication adherence
- MeSH terms
- Adolescent, Adult, Aged, Allergens, Desensitization, Immunologic, Female, Humans, Hypersensitivity, Immunoglobulin E, Immune Tolerance, Injections, Intralymphatic, Injections, Subcutaneous, Male, Middle Aged, Pain, Skin Tests, Time Factors, Treatment Outcome, Anti-Allergic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.